Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE Trial

David B. DeLurgio(Emory University), Jaswinder Gill(St Thomas' Hospital), Eric Espinal(Summa Health System), David Gilligan(University of Cambridge), Michael E. Halkos(Emory University), Sreedhar R. Billakanty(OhioHealth), Christopher Blauth(St Thomas' Hospital), Paul B. Tabereaux, Anthony R. Magnano(Saint Vincent Health System), James L. Garrison(Guy's and St Thomas' NHS Foundation Trust), Jason S. Sperling(HealthONE), Mark A. Mostovych(St. Vincent's Medical Center), Christian Shults(LMU Klinikum), Felix Yang(University of Oklahoma), Angelo La Pietra(Mount Sinai Medical Center), Steven B. Duff(OhioHealth), Yisachar Greenberg(Maimonides Medical Center), Karl J. Crossen, Christopher Stees(HealthONE), Graham M. Bundy(Virginia Cancer Specialists), Syed Ahsan, John Yap(St Bartholomew's Hospital), Israel J. Jacobowitz(Maimonides Medical Center), Otto Costantini(Summa Health System), David Talton, Saumil R. Oza(Saint Vincent Health System), David R. Pederson(Western University)
Heart Rhythm O2
December 5, 2022
Cited by 19


Related Papers